Literature DB >> 26233504

Patient Expectations and Perceptions of Goal-setting Strategies for Disease Management in Rheumatoid Arthritis.

Vibeke Strand1, Grace C Wright2, Martin J Bergman2, Jeyanesh Tambiah2, Peter C Taylor2.   

Abstract

OBJECTIVE: To identify how patients perceive the broad effect of active rheumatoid arthritis (RA) on their daily lives and indicate how RA disease management could benefit from the inclusion of individual goal-setting strategies.
METHODS: Two multinational surveys were completed by patients with RA. The "Good Days Fast" survey was conducted to explore the effect of disease on the daily lives and relationships of women with RA. The "Getting to Your Destination Faster" survey examined RA patients' treatment expectations and goal-setting practices.
RESULTS: Respondents from all countries agreed that RA had a substantial negative effect on many aspects of their lives (work productivity, daily routines, participation in social and leisure activities) and emotional well-being (loss of self-confidence, feelings of detachment, isolation). Daily pain was a paramount issue, and being pain- and fatigue-free was considered the main indicator of a "good day." Setting personal, social, and treatment goals, as well as monitoring disease progress to achieve these, was considered very beneficial by patients with RA, but discussion of treatment goals seldom appeared to be a part of medical appointments.
CONCLUSION: Many patients with RA feel unable to communicate their disease burden and treatment goals, which are critically important to them, to their healthcare provider (HCP). Insights gained from these 2 surveys should help to guide patients and HCP to better focus upon mutually defined goals for continued improvement of management and achievement of optimal care in RA.

Entities:  

Keywords:  PATIENT SATISFACTION; PATIENT SURVEY; QUALITY OF LIFE; RHEUMATOID ARTHRITIS

Mesh:

Year:  2015        PMID: 26233504     DOI: 10.3899/jrheum.140976

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  22 in total

1.  Expert recommendations on the psychological needs of patients with rheumatoid arthritis.

Authors:  Leticia Leon; Marta Redondo; Antonio Fernández-Nebro; Susana Gómez; Estíbaliz Loza; María Montoro; Rosario Garcia-Vicuña; María Galindo
Journal:  Rheumatol Int       Date:  2018-05-28       Impact factor: 2.631

2.  Examination of Patient-Reported Outcomes in Association with TNF-Inhibitor Treatment Response: Results from a US Observational Cohort Study.

Authors:  Cynthia J Larmore; Natalie N Boytsov; Carol L Gaich; Xiang Zhang; Andre B Araujo; Sabrina Rebello; Bob A Salim; George W Reed; Leslie R Harrold
Journal:  Rheumatol Ther       Date:  2018-01-10

Review 3.  Fatigue in Rheumatoid Arthritis.

Authors:  Patricia Katz
Journal:  Curr Rheumatol Rep       Date:  2017-05       Impact factor: 4.592

4.  Discordance of global assessment by patients and physicians is higher in osteoarthritis than in rheumatoid arthritis: a cross-sectional study from routine care.

Authors:  Isabel Castrejon; Najia Shakoor; Jacquelin R Chua; Joel A Block
Journal:  Rheumatol Int       Date:  2018-10-06       Impact factor: 2.631

5.  Are We on the Same Page?: A Cross-Sectional Study of Patient-Clinician Goal Concordance in Rheumatoid Arthritis.

Authors:  Jennifer L Barton; Sheila Markwardt; Meike Niederhausen; Allison Schue; Jacob Dougherty; Patricia Katz; Somnath Saha; Edward H Yelin
Journal:  Arthritis Care Res (Hoboken)       Date:  2021-09-27       Impact factor: 4.794

6.  Relationship between clinical and patient-reported outcomes in a phase 3 trial of tofacitinib or MTX in MTX-naïve patients with rheumatoid arthritis.

Authors:  Roy Fleischmann; Vibeke Strand; Bethanie Wilkinson; Kenneth Kwok; Eustratios Bananis
Journal:  RMD Open       Date:  2016-04-26

7.  Efficacy and safety of sarilumab monotherapy versus adalimumab monotherapy for the treatment of patients with active rheumatoid arthritis (MONARCH): a randomised, double-blind, parallel-group phase III trial.

Authors:  Gerd R Burmester; Yong Lin; Rahul Patel; Janet van Adelsberg; Erin K Mangan; Neil M H Graham; Hubert van Hoogstraten; Deborah Bauer; Juan Ignacio Vargas; Eun Bong Lee
Journal:  Ann Rheum Dis       Date:  2016-11-17       Impact factor: 19.103

8.  High Disease Activity May Increase Fear-Avoidance Beliefs in Rheumatoid Arthritis.

Authors:  Mehmet Engin Tezcan; Berfu Cinkit Doğan; Nesrin Şen; Mehmet Sargin
Journal:  Arch Rheumatol       Date:  2017-04-24       Impact factor: 1.472

9.  Discordance between patient and physician assessments of global disease activity in rheumatoid arthritis and association with work productivity.

Authors:  Josef S Smolen; Vibeke Strand; Andrew S Koenig; Annette Szumski; Sameer Kotak; Thomas V Jones
Journal:  Arthritis Res Ther       Date:  2016-05-21       Impact factor: 5.156

10.  Impact of intensive treatment and remission on health-related quality of life in early and established rheumatoid arthritis.

Authors:  I C Scott; F Ibrahim; C M Lewis; D L Scott; V Strand
Journal:  RMD Open       Date:  2016-08-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.